Dermatology News

Compared with standard of care, once-daily daptomycin, a parenteral lipopeptide antibiotic, demonstrated significant effectiveness and safety for the treatment of complicated skin and skin structure infections caused by gram-positive pathogens, including community-acquired methicillin-resistant Staphylococcus aureus.

Taksta oral tablets were noninferior to Zyvox in treating skin infections such as MRSA in a recent phase 3 clinical trial, the experimental drug’s manufacturer announced.

Through examination of a medieval skeleton excavated from a leprosy hospital cemetery in Winchester, UK, researchers found no significant change in the M. leprae genome since the late 11th century, which could explain how disease transmission rates declined as resistance grew, according to research published in PLoS Neglected Tropical Diseases.

The first patient to acquire Zika virus from a mosquito in the United States was a pregnant woman in Florida who sought treatment for a rash and other symptoms and eventually gave birth to a healthy full-term baby, according to doctors who treated her.

Data from a phase 2b trial examining the safety and efficacy of the therapeutic vaccine GEN-003 for the treatment of genital herpes showed that three doses of treatment reduced the rate of genital lesions as well as the number and duration of recurrences 6 months after administration compared with placebo, according to a press release.

Opening a supervised injection facility for people who inject drugs, or PWID, could generate $3.5 million in savings in San Francisco, according to a cost-benefit analysis published in the Journal of Drug Issues.

Periumbilical skin and soft-tissue infections can develop in newborns from security devices intended to prevent abduction, according to a recent investigation.

Inter-nasal antibiotic-resistant Staphylococcus aureus was associated with recent symptoms of skin and soft tissue infections in individuals who work on large industrial hog operations, according to recent study findings.

Days after winning the White House, President-elect Donald J. Trump declared during a TV interview that he would try to keep in place parts of the Affordable Care Act guaranteeing coverage for patients with pre-existing conditions and allowing children to remain on their parents’ health care plans until age 26 years — comments that seemed at odds with his persistent campaign pledge to “repeal and replace” President Barack Obama’s signature health care law.

Days after winning the White House, President-elect Donald J. Trump declared during a TV interview that he would try to keep in place parts of the Affordable Care Act guaranteeing coverage for patients with pre-existing conditions and allowing children to remain on their parents’ health care plans until age 26 years — comments that seemed at odds with his persistent campaign pledge to “repeal and replace” President Barack Obama’s signature health care law.